Joseph Schwartz

Q: What is Joseph Schwartz's success rate?

Joseph Schwartz currently has a success rate of 85.30220256784386.

Q: What is the average return of Joseph Schwartz's calls?

Their stock ratings have generated an average return of 29.46652767220623.

Leerink Partners | Healthcare

Joseph Schwartz is an analyst from Leerink Partners specializing in the Healthcare sector. Ranked #901 out of 4655 analysts, they have issued 21 stock ratings with a success rate of 85.30% and an average return of 29.47%.

Joseph Schwartz has a well-established track record, with 21 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 85.30% and an average return of 29.47%, underscoring their expertise and ability to identify winning opportunities for investors.

#901

Out of 4655

Total Ratings

+85.30%

Success Rate

+29.47%

Average Return

Recent Ratings Analysis

ANTX

Buy

May 14, 2026

Target

$9.00

Current

$4.64

Performance

0.00%

Joseph Schwartz rated ANTX as Outperform on May 14, 2026, setting a price target of 9. Shares have remained stable near 4.64, leaving the 9 target still in play.

MSLE

Buy

Apr 06, 2026

Target

$20.00

Current

$7.17

Performance

26.90%

On Apr 06, 2026, MSLE was given a Outperform rating by Joseph Schwartz, with a target price of 20. The stock rallied 26.90% after the rating, narrowing the gap to the target of 20 and validating the bullish stance.

INSM

Buy

Mar 24, 2026

Target

$215.00

Current

$115.62

Performance

-16.90%

INSM received a Outperform rating from Joseph Schwartz on Mar 24, 2026, aiming for 215. The rating hasn’t played out as hoped, with the stock trading 16.90% below expectations.

GOSS

Hold

Feb 24, 2026

Target

$6.00

Current

$0.33

Performance

-20.56%

On Feb 24, 2026, Joseph Schwartz published a Market Perform outlook on GOSS, with a target of 6. Weakness in the stock, now at 0.33, supported the conservative rating.

RARE

Buy

Dec 30, 2025

Target

$80.00

Current

$25.80

Performance

13.26%

Joseph Schwartz on Dec 30, 2025 assigned RARE a Outperform rating, with a price target of 80. The Buy call aligned well with market performance, producing a gain of 13.26%.

FOLD

Hold

Dec 29, 2025

Target

$17.00

Current

$14.49

Performance

1.68%

On Dec 29, 2025, Joseph Schwartz reaffirmed FOLD with a Market Perform rating, targeting 17. The neutral call matched muted market action of 1.68%.

AUPH

Hold

Dec 03, 2025

Target

$16.00

Current

$15.84

Performance

6.24%

AUPH was rated Market Perform by Joseph Schwartz on Dec 03, 2025, with a price objective of 16. Despite caution, upside momentum rewarded risk-takers with gains to 15.84.

APLT

Hold

Dec 03, 2025

Target

$2.00

Current

$0.10

Performance

-51.23%

On Dec 03, 2025, Joseph Schwartz initiated coverage on APLT with a Market Perform rating and target of 2. The rating matched the stock’s inability to hold above 0.103.

BMRN

Hold

Dec 03, 2025

Target

$82.00

Current

$53.24

Performance

-1.97%

Joseph Schwartz issued a Market Perform recommendation for BMRN on Dec 03, 2025, price target set at 82. The rating was appropriate for a consolidating market trading near 53.24.

DSGN

Buy

Dec 03, 2025

Target

$14.00

Current

$14.54

Performance

48.82%

On Dec 03, 2025, DSGN was evaluated by Joseph Schwartz, who gave a Outperform rating and target of 14. This case illustrates how a timely bullish rating can translate into tangible gains of 48.82%.

SPRB

Buy

Dec 03, 2025

Target

$160.00

Current

$59.00

Performance

-34.56%

Joseph Schwartz rated SPRB as Outperform on Dec 03, 2025, setting a price target of 160. The stock has underperformed, dropping 34.56% despite the bullish target of 160.

IFRX

Hold

Dec 03, 2025

Target

$5.00

Current

$2.38

Performance

133.33%

On Dec 03, 2025, IFRX was given a Market Perform rating by Joseph Schwartz, with a target price of 5. The stock rallied from 2.38 to 2.38 after the Hold rating, surprising to the upside.

QURE

Buy

Nov 10, 2025

Target

$60.00

Current

$27.75

Performance

6.12%

QURE received a Outperform rating from Joseph Schwartz on Nov 10, 2025, aiming for 60. Momentum has favored the Buy call, with shares climbing from 27.75 to 27.75, rewarding those who trusted the recommendation.

MNPR

Buy

Nov 10, 2025

Target

$115.00

Current

$60.99

Performance

-26.59%

On Nov 10, 2025, Joseph Schwartz published a Outperform outlook on MNPR, with a target of 115. Market action contradicted the Buy thesis, as shares slipped to 60.99.

RNA

Hold

Oct 27, 2025

Target

$72.00

Current

$13.27

Performance

-81.04%

Joseph Schwartz on Oct 27, 2025 assigned RNA a Market Perform rating, with a price target of 72. The call successfully avoided chasing as shares lost 81.04%.

CRNX

Buy

Sep 29, 2025

Target

$88.00

Current

$38.31

Performance

-11.95%

On Sep 29, 2025, Joseph Schwartz reaffirmed CRNX with a Outperform rating, targeting 88. Shares slid 11.95% despite the recommendation, highlighting downside risks.

SRPT

Hold

Sep 09, 2025

Target

$15.00

Current

$18.68

Performance

5.90%

SRPT was rated Market Perform by Joseph Schwartz on Sep 09, 2025, with a price objective of 15. Despite caution, upside momentum rewarded risk-takers with gains to 18.68.

KALV

Buy

Jul 07, 2025

Target

$20.00

Current

$26.76

Performance

77.69%

On Jul 07, 2025, Joseph Schwartz initiated coverage on KALV with a Outperform rating and target of 20. The stock’s climb of 77.69% since the call highlights the foresight in the rating.

RGLS

Hold

Apr 30, 2025

Target

$7.00

Current

$8.16

Performance

2.26%

Joseph Schwartz issued a Market Perform recommendation for RGLS on Apr 30, 2025, price target set at 7. The rating was appropriate for a consolidating market trading near 8.16.

MAZE

Buy

Feb 25, 2025

Target

$28.00

Current

$26.43

Performance

150.05%

On Feb 25, 2025, MAZE was evaluated by Joseph Schwartz, who gave a Outperform rating and target of 28. This case illustrates how a timely bullish rating can translate into tangible gains of 150.05%.

TVTX

Buy

Oct 11, 2024

Target

$40.00

Current

$44.10

Performance

168.74%

Joseph Schwartz rated TVTX as Outperform on Oct 11, 2024, setting a price target of 40. The call has proven timely, with shares rising 168.74% toward the price target of 40.

FULC

Hold

Sep 12, 2024

Target

$4.00

Current

$7.11

Performance

106.69%

On Sep 12, 2024, FULC was given a Market Perform rating by Joseph Schwartz, with a target price of 4. The stock rallied from 7.11 to 7.11 after the Hold rating, surprising to the upside.

SLDB

Buy

Jun 24, 2024

Target

$12.00

Current

$7.63

Performance

15.26%

SLDB received a Outperform rating from Joseph Schwartz on Jun 24, 2024, aiming for 12. Momentum has favored the Buy call, with shares climbing from 7.63 to 7.63, rewarding those who trusted the recommendation.

MREO

Buy

Jun 20, 2024

Target

$8.00

Current

$0.25

Performance

-93.68%

On Jun 20, 2024, Joseph Schwartz published a Outperform outlook on MREO, with a target of 8. Market action contradicted the Buy thesis, as shares slipped to 0.246.

Frequency Asked Questions

Who is Joseph Schwartz?

Joseph Schwartz is an analyst from Leerink Partners specializing in the Healthcare sector.

What is Joseph Schwartz's success rate?

Joseph Schwartz currently has a success rate of +85.30%.

How many ratings has Joseph Schwartz issued?

Joseph Schwartz has issued 21 stock ratings so far.

What is the average return of Joseph Schwartz's calls?

Their stock ratings have generated an average return of +29.47%.

What is Joseph Schwartz's ranking?

Joseph Schwartz is ranked #901 out of 4655 analysts.

What types of ratings does Joseph Schwartz give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Joseph Schwartz?

You can follow Joseph Schwartz by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Joseph Schwartz?

Their latest rating was a Buy on ANTX issued on 2026-05-14.